Biomerica Inc (BMRA)
0.6499
-0.01
(-1.60%)
USD |
NASDAQ |
May 21, 14:56
Biomerica Gross Profit Margin (Quarterly): -14.65% for Feb. 29, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -14.65% |
| November 30, 2023 | 20.74% |
| August 31, 2023 | 24.05% |
| May 31, 2023 | 2.62% |
| February 28, 2023 | 10.80% |
| November 30, 2022 | 23.75% |
| August 31, 2022 | -3.36% |
| May 31, 2022 | 11.71% |
| February 28, 2022 | 21.84% |
| November 30, 2021 | 16.61% |
| August 31, 2021 | -7.05% |
| May 31, 2021 | 1.22% |
| February 28, 2021 | -2.02% |
| November 30, 2020 | 22.49% |
| August 31, 2020 | 10.32% |
| May 31, 2020 | 25.32% |
| February 29, 2020 | 18.01% |
| November 30, 2019 | 29.37% |
| August 31, 2019 | 30.75% |
| May 31, 2019 | 15.51% |
| February 28, 2019 | 29.01% |
| November 30, 2018 | 27.19% |
| August 31, 2018 | 26.49% |
| May 31, 2018 | 23.73% |
| February 28, 2018 | 33.83% |
| Date | Value |
|---|---|
| November 30, 2017 | 31.37% |
| August 31, 2017 | 35.62% |
| May 31, 2017 | 30.27% |
| February 28, 2017 | 29.96% |
| November 30, 2016 | 38.87% |
| August 31, 2016 | 40.92% |
| May 31, 2016 | 26.10% |
| February 29, 2016 | 25.30% |
| November 30, 2015 | 35.37% |
| August 31, 2015 | 32.74% |
| May 31, 2015 | 31.16% |
| February 28, 2015 | 35.31% |
| November 30, 2014 | 27.10% |
| August 31, 2014 | 29.96% |
| May 31, 2014 | 34.23% |
| February 28, 2014 | 38.76% |
| November 30, 2013 | 27.35% |
| August 31, 2013 | 25.68% |
| May 31, 2013 | 32.71% |
| February 28, 2013 | 31.44% |
| November 30, 2012 | 40.83% |
| August 31, 2012 | 43.02% |
| May 31, 2012 | 35.44% |
| February 29, 2012 | 37.42% |
| November 30, 2011 | 41.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-14.65%
Minimum
Feb 2024
30.75%
Maximum
Aug 2019
12.90%
Average
16.06%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 25.01% |
| Xtant Medical Holdings Inc | 62.07% |
| Asensus Surgical Inc | -172.1% |
| Catheter Precision Inc | 93.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.51% |
| Return on Assets | -54.68% |
| Return on Invested Capital | -69.51% |
| Profit Margin (Quarterly) | -188.6% |
| Operating Margin (Quarterly) | -196.7% |
| Return on Net Operating Assets | -143.6% |